首页|监测肾素、醛固酮与预防性干预妊娠期高血压的临床研究

监测肾素、醛固酮与预防性干预妊娠期高血压的临床研究

扫码查看
目的 分析肾素和醛固酮水平监测及预防性干预措施在妊娠期高血压孕妇中的应用效果。方法 抽取 135 例孕妇,其中 45 例健康孕妇作为健康组;其余 90 例妊娠期高血压孕妇按随机信封法分为对照组和观察组,各 45 例。对照组孕妇不监测肾素和醛固酮水平,直接使用药物干预,观察组孕妇监测肾素及醛固酮水平,并采取预防性干预措施。检测并对比健康组和观察组孕妇肾素、醛固酮水平;对比对照组和观察组孕妇血压水平、不良妊娠结局发生情况。结果 观察组孕妇入组时及孕 20、28、36 周肾素和醛固酮水平分别为(0。26±0。19)、(0。25±0。16)、(0。24±0。18)、(0。23±0。16)ng/(ml·h)和(12。81±3。39)、(12。79±3。46)、(12。72±3。37)、(12。70±2。97)ng/dl,均低于健康组的(0。36±0。21)、(0。37±0。18)、(0。36±0。20)、(0。36±0。19)ng/(ml·h)和(15。43±3。57)、(15。50±3。58)、(15。51±3。54)、(15。43±3。85)ng/dl(P<0。05)。孕 28、36 周,两组孕妇收缩压和舒张压水平均低于入组时(P<0。05);观察组孕妇孕 28、36 周收缩压和舒张压水平分别为(134。75±4。49)、(127。26±5。45)和(83。34±4。17)、(82。86±4。23)mm Hg(1 mm Hg=0。133 kPa),均低于对照组的(146。52±4。64)、(145。75±4。71)和(92。39±3。51)、(92。77±3。46)mm Hg(P<0。05)。观察组孕妇早产率 0 及剖宫产率 40。00%均低于对照组的 13。33%、82。22%(P<0。05);观察组孕妇胎儿窘迫、羊水异常、产后出血发生率均略低于对照组,但差异不明显(P>0。05)。结论 妊娠期高血压孕妇肾素及醛固酮水平均低于健康孕妇,通过对妊娠期高血压孕妇监测肾素和醛固酮水平,建立预警机制,并开展预防性干预措施可提升血压控制效果,并有助于改善妊娠结局。
Clinical study of monitoring renin and aldosterone and preventive intervention for gestational hypertension
Objective To analyze the application effect of renin and aldosterone level monitoring and preventive interventions in pregnant women with gestational hypertension.Methods 135 pregnant women were sampled,of which 45 healthy pregnant women served as the healthy group;the remaining 90 pregnant women with gestational hypertension were divided into a control group and an observation group according to the randomized envelope method,each with 45 cases.Pregnant women in the control group were not monitored for renin and aldosterone levels and were directly intervened with medication,while pregnant women in the observation group were monitored for renin and aldosterone levels and preventive interventions were taken.The renin and aldosterone levels of pregnant women were detected and compared bewteen the healthy group and the observation group;the blood pressure levels and the occurrence of adverse pregnancy outcome were compaared between the control group and the observation group.Results The levels of renin and aldosterone in the observation group at the time of enrollment and at 20,28 and 36 weeks of gestation were(0.26±0.19),(0.25±0.16),(0.24±0.18),(0.23±0.16)ng/(ml·h)and(12.81±3.39),(12.79±3.46),(12.72±3.37),(12.70±2.97)ng/dl,which were lower than(0.36±0.21),(0.37±0.18),(0.36±0.20),(0.36±0.19)ng/(ml·h),and(15.43±3.57),(15.50±3.58),(15.51±3.54),(15.43±3.85)ng/dl in the healthy group(P<0.05).At 28 and 36 weeks of pregnancy,the systolic and diastolic blood pressure in both groups were lower than those at the time of enrollment(P<0.05).At 28 and 36 weeks of gestation,the systolic and diastolic blood pressure in the observation group were(134.75±4.49),(127.26±5.45)and(83.34±4.17),(82.86±4.23)mm Hg(1 mm Hg=0.133 kPa),which were lower than(146.52±4.64),(145.75±4.71)and(92.39±3.51),(92.77±3.46)mm Hg in the control group(P<0.05).The rates of preterm labor of 0 and cesarean section of 40.00%in the observation group were lower than 13.33%and 82.22%in the control group(P<0.05).The incidence of fetal distress,abnormal amniotic fluid and postpartum hemorrhage in the observation group was slightly lower than those in the control group,but the difference was not significant(P>0.05).Conclusion Renin and aldosterone levels in pregnant women with gestational hypertension are lower than those in healthy pregnant women.Monitoring renin and aldosterone levels in pregnant women with gestational hypertension,establishing an early warning mechanism,and carrying out preventive interventions can enhance the effectiveness of blood pressure control and help to improve the pregnancy outcome.

ReninAldosteronePreventive interventionGestational hypertensionPregnancy outcome

孙健、曲春尧、聂雯雯、刘丹丹、张益萌

展开 >

154004 佳木斯市妇幼保健院

肾素 醛固酮 预防性干预措施 妊娠期高血压 妊娠结局

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(24)